Scientific publications

Delayed Effect and Gain Restoration After Intratympanic Gentamicin for Menière's Disease

Martin-Sanz E (1,2), Diaz JY (1,2), Esteban-Sanchez J (1,2), Sanz-Fernández R (1,2), Perez-Fernandez N (1,2).

(1) Department of Otolaryngology, University Hospital of Getafe.
(2) Department of Otolaryngology, Clinica Universidad de Navarra, Madrid, Spain.

Magazine: Otology & Neurotology

Date: Oct 16, 2018

OBJECTIVE:

This study aimed to evaluate the changes in the VOR gain after intratympanic gentamicin therapy and to correlate them with the mid-term effects on the control of vertigo, in a population of Menière's disease patients.

STUDY DESIGN:

The study design was a prospective "Outcomes research."

SETTING:

Tertiary referral center.

PATIENTS:

This study included 20 patients with unilateral Menière's disease refractory to medical therapy for at least 1 year, and treated with an on demand intratympanic gentamicin protocol.

INTERVENTION:

Therapeutic.

MAIN OUTCOME MEASURE:

Audiometry, caloric testing, and a vHIT before beginning the protocol were performed. Patients underwent weekly vHIT assessments until a significant gain reduction was observed. Subsequently we performed vHIT tests 1 month after the therapy completion, and then every 3 months for at least 1 year.

RESULTS:

Complete vertigo control (class A) was achieved in 14 patients at the 12-month follow-up assessment. We observed a significant reduction in VOR gain values at the 3-week follow-up assessment. We found a significant correlation between the 1-month posttreatment ipsilateral hVOR gain and the rate of vertigo recurrence after the first IT gentamicin treatment (p = 0.012; r = 0.400). At the mid-term assessment, 10 patients exhibited a significant partial recovery of the hVOR gain.

CONCLUSIONS:

The delayed effect of intratympanic gentamicin and the subsequent gain restoration are factors that may influence the patients' outcome. The feasibility of the vHIT system makes it a useful tool to monitorize the VOR changes.

CITATION  Otol Neurotol. 2018 Oct 16. doi: 10.1097/MAO.0000000000001973

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra